Warren Davis, PhD

Department of Cancer Prevention and Control

Positions

Roswell Park Comprehensive Cancer Center

  • Department of Cancer Prevention and Control

Background

Education and Training

  • 1999 - PhD - Cancer Research, Institute of Cancer Research, University of London, UK
  • 1993 - BSc (Hons) - Biochemistry and Toxicity, University of Surrey, Guildford, UK

Publications

  Full Publications list on PubMed

Ambrosone CB, Nesline MK, Davis W. Establishing a cancer center data bank and biorepository for multidisciplinary research. Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1575-7. PMID: 16985014

Kwan ML, Ambrosone CB, Lee MM, Barlow J, Krathwohl SE, Ergas IJ, Ashley CH, Bittner JR, Darbinian J, Stronach K, Caan BJ, Davis W, Kutner SE, Quesenberry CP, Somkin CP, Sternfeld B, Wiencke JK, Zheng S, Kushi LH. The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control. 2008 Dec;19(10):1065-76. PMCID: PMC2581640

Ambrosone CB, Ciupak GL, Bandera EV, Jandorf L, Bovbjerg DH, Zirpoli G, Pawlish K, Godbold J, Furberg H, Fatone A, Valdimarsdottir H, Yao S, Li Y, Hwang H, Davis W, Roberts M, Sucheston L, Demissie K, Amend KL, Tartter P, Reilly J, Pace BW, Rohan T, Sparano J, Raptis G, Castaldi M, Estabrook A, Feldman S, Weltz C, Kemeny M. Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women. J Oncol. 2009;2009:871250. PMCID: PMC2766507.

Ondracek RP, Chen J, Marosy B, Szewczyk S, Medico L, Mohan AS, Nair P, Pratt R, Roh JM, Khoury T, Carpten J, Kushi LH, Palmer JR, Doheny K, Davis W, Higgins MJ, Yao S, Ambrosone CB. Results and lessons from dual extraction of DNA and RNA from formalin-fixed paraffin-embedded breast tumor tissues for a large Cancer epidemiologic study. BMC Genomics. 2022 Aug 25;23(1):614. doi: 10.1186/s12864-022-08837-6. PubMed PMID: 36008758; PubMed Central PMCID: PMC9404650.

Khoury T, Mendicino L, Payne Ondracek R, Yao S, Davis W, Omilian AR, Kwan ML, Roh JM, D'Addario L, Valice E, Fernandez D, Ergas IJ, Chua AV Jr, Ambrosone CB, Kushi LH. Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in Breast Cancer. JAMA Netw Open. 2024 Mar 4;7(3):e243345. doi: 10.1001/jamanetworkopen.2024.3345. PubMed PMID: 38517439; PubMed Central PMCID: PMC10960203.